About the Authors

Fiona M. Blows, Kristy E. Driver, Elena Provenzano, Sarah-Jane Dawson, Alison M. Dunning, Douglas F. Easton, Carlos Caldas, Paul D. Pharoah
Department of Oncology, University of Cambridge, United Kingdom

Marjanka K. Schmidt, Annegien Broeks, Flora E. van Leeuwen, Jelle Wesseling
Netherlands Cancer Institute, Amsterdam, The Netherlands

Maggie C. Cheang, Karen Gelmon, Torsten O. Nielsen, David Huntsman
Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, Canada

Carl Blomqvist
Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland

Päivi Heikkilä
Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland

Tuomas Heikkinen, Heli Nevanlinna
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland

Lars A. Akslen
The Gade Institute, Section for Pathology, University of Bergen, Haukeland University Hospital, Bergen, Norway

Louis R. Bégin
Department of Pathology, McGill University and Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada

William D. Foulkes
Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada

Fergus J. Couch, Xianshu Wang
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

Vicky Cafourek, Janet E. Olson
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America

Laura Baglietto, Graham G. Giles, Gianluca Severi
Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia

Catriona A. McLean
The Alfred Hospital, Melbourne, Australia

Melissa C. Southey
Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Australia

Emad Rakha, Andrew R. Green, Ian O. Ellis
Departments of Histopathology and Surgery, The Breast Unit, Nottingham City Hospital NHS Trust and University of Nottingham, Nottingham, United Kingdom

Mark E. Sherman, William F. Anderson, Montserrat García-Closas
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America

Jolanta Lissowska
M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland

Angela Cox
Institute for Cancer Studies, University of Sheffield School of Medicine, Sheffield, United Kingdom

Simon S. Cross
Academic Unit of Pathology, University of Sheffield School of Medicine, Sheffield, United Kingdom

Malcolm W. R. Reed
Academic Unit of Surgical Oncology, University of Sheffield School of Medicine, Sheffield, United Kingdom

Alison M. Dunning, Manjeet Humphreys, Douglas F. Easton, Paul D. Pharoah
Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

Corresponding Author

paul.pharoah@srl.cam.ac.uk

Competing Interests

Research in the Genetic Pathology Evaluation Centre is supported in part by an unrestricted educational grant from sanofi-aventis Canada.

Author Contributions

ICMJE criteria for authorship read and met: FMB KED MKS AB FEvL JW MCC KG TON CB PH TH HN LA LRB WF FJC XW VC JEO LB GGG GS CAM MCS ER ARG IOE MES JL WA AC SSC MWRR EP SJD AMD MKH DFE MGC CC PDP DH. Agree with the manuscript's results and conclusions: FMB KED MKS AB FEvL JW MCC KG TON CB PH TH HN LA LRB WF FJC XW VC JEO LB GGG GS CAM MCS ER ARG IOE MES JL WA AC SSC MWRR EP SJD AMD MKH DFE MGC CC PDP DH. Designed the experiments/the study: TON PH MCS IOE JL AMD MGC CC PDP DH. Analyzed the data: FMB KED PH LRB XW MCS MES WA CC PDP. Collected data/did experiments for the study: FMB KED MKS AB JW MCC TON CB PH TH HN LA LRB WF FJC XW VC LB GGG GS CAM MCS ER ARG MES JL AC SSC EP SJD MKH DFE MGC CC PDP DH. Enrolled patients: FEvL KG FJC JEO LB GGG MCS IOE JL MWRR DFE MGC PDP DH. Wrote the first draft of the paper: FMB KED. Contributed to the writing of the paper: MKS FEvL JW KG TON CB PH TH HN LA WF FJC XW JEO LB GGG GS CAM MCS IOE MES JL WA AC SSC MWRR EP SJD DFE MGC CC PDP. Co-ordinated data collation: FMB KED. Contributed to database building and checking of data: MKS. Enrolled patients are derived from a cohort built by me and others: FEvL. Responsible for clinical data integrity: VC. Assistance with TMA construction and scoring of immunohistochemistry: EP. Responsible for pooling data and data cleaning: MH.